arrow
B

Brennan Decker

foundation medicine
H指数:25
被引数:3,958

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

High-Specificity Detection of Ultraviolet Mutational Signatures in Circulating Tumor DNA for Diagnostic Classification of Cutaneous and Unknown Primary Tumors using FoundationOne Liquid CDx

使用FoundationOne Liquid CDx对循环肿瘤DNA进行高特异性检测,以诊断分类皮肤癌和原发部位不明的肿瘤中的紫外线突变特征。

2025-08-200
OAAI
Technical Advance, FoundationOne CDx and FoundationOne Heme Detect Epstein-Barr Virus with High Sensitivity and Specificity

技术先进,FoundationOne CDx和FoundationOne Heme以高灵敏度和特异性检测EB病毒

2025-07-230
OAAI
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab
2024-09-140
OAAI
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer
2024-07-014
OA
Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results
2024-02-292
PRE
POU2AF3-rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2
2023-03-319
PRE
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer
2022-12-0518
OAAI
Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinoma
2022-11-012
OAAI
Method of Tissue Acquisition Affects Success of Comprehensive Genomic Profiling in Lung Cancer
2022-06-307
OA